Publications

Factors Associated With Disparities in Hospital Readmission Rates Among US Adults Dually Eligible for Medicare and Medicaid.

JAMA Health Forum
Silvestri D, Goutos D, Lloren A, Zhou S, Zhou G, Farietta T, Charania S, Herrin J, Peltz A, Lin Z, Bernheim S

Prenatal phthalates, gestational weight gain, and long-term weight changes among Mexican women.

Environ Res
Deierlein AL, Wu H, Just AC, Kupsco AJ, Braun JM, Oken E, Soria-Contreras DC, Cantoral A, Pizano ML, McRae N, Téllez-Rojo MM, Wright RO, Baccarelli AA

What has the pandemic revealed about the shortcomings of modern epidemiology? What can we fix or do better?

Am J Epidemiol
Dimitris MC, Galea S, Marcus JL, Pan A, Sander B, Platt RW

One Pill, Once a Day: Simplified Treatment Regimens and Retention in HIV Care.

Am J Epidemiol
Bor J, Kluberg SA, LaValley MP, Evans D, Hirasen K, Maskew M, Long L, Fox MP

A Smoothed Version of the Lassosum Penalty for Fitting Integrated Risk Models Using Summary Statistics or Individual-Level Data

Genes (Basel)
Hahn G, Prokopenko D, Lutz SM, Mullin K, Tanzi RE, Cho MH, Silverman EK, Lange C, On The Behalf Of The Nhlbi Trans-Omics For Precision Medicine TOPMed Consortium.

Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant

JAMA
Klompas M, Karan A.

Modeling Genomic Screening in Newborns.

JAMA Pediatr
Lu CY, McMahon PM, Wu AC

Variation in Condition-Specific Readmission Rates Across U.S. Children's Hospitals.

Acad Pediatr
Gay JC, Teufel Ii RJ, Peltz A, Auger KA, Harris JM, Hall M, Neuman MI, Simon HK, Morse R, Eghtesady P, McClead R, Shah SS

ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes.

Diabetes Care
Nolan JJ, Kahkoska AR, Semnani-Azad Z, Hivert MF, Ji L, Mohan V, Eckel RH, Philipson LH, Rich SS, Gruber C, Franks PW

Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 - United States, March 2020-August 2021.

MMWR Morb Mortal Wkly Rep
Wiltz JL, Feehan AK, Molinari NM, Ladva CN, Truman BI, Hall J, Block JP, Rasmussen SA, Denson JL, Trick WE, Weiner MG, Koumans E, Gundlapalli A, Carton TW, Boehmer TK

Prevalence and Outcomes of Previously Healthy Adults Among Patients Hospitalized with Community-Onset Sepsis

Chest.
Mohammad AlrawashdehP, Michael Klompas, Steven Q. Simpson, Sameer S.Kadri, Russell Poland, Jeffrey S. Guy, Jonathan B. Perlin, Chanu Rhee, for theCDC Prevention Epicenters Program

Comparison of estimation methods and sample size calculation for parameter-driven interrupted time series models with count outcomes

Health Services and Outcomes Research Methodology
Ye S, Wang R*, Zhang B*.

Population-Based Newborn Screening for Germline TP53 Variants: Clinical Benefits, Cost-Effectiveness, and Value of Further Research.

J Natl Cancer Inst
Kunst N, Stout NK, O'Brien G, Christensen KD, McMahon PM, Wu AC, Diller L, Yeh JM

Incidence, Characteristics, and Outcomes of Ventilator-associated Events during the COVID-19 Pandemic

Ann Am Thorac Soc
Weinberger J, Rhee C, Klompas M.

New Insights into the Prevention of Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Caused by Viruses

Semin Respir Crit Care Med.
Michael Klompas

Strategies commercially-insured families use to manage the cost of asthma care: A qualitative interview study.

J Asthma
Gilkey MB, Cripps LA, Przywara KM, Batista MI, Galbraith AA

Human plasma pregnancy-associated miRNAs and their temporal variation within the first trimester of pregnancy.

Reprod Biol Endocrinol
Légaré C, Clément AA, Desgagné V, Thibeault K, White F, Guay SP, Arsenault BJ, Scott MS, Jacques PÉ, Perron P, Guérin R, Hivert MF, Bouchard L

Estimated causal effects of complementary feeding behaviors on early childhood diet quality in a US cohort.

Am J Clin Nutr
Switkowski KM, Aris IM, Gingras V, Oken E, Young JG

Comparison of Ambulatory Care Access and Quality for Beneficiaries With Disabilities Covered by Medicare Advantage vs Traditional Medicare Insurance.

JAMA Health Forum
Johnston KJ, Wen H, Pollack HA

Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.

JAMA Dermatol
Tang K, Seo J, Tiu BC, Le TK, Pahalyants V, Raval NS, Ugwu-Dike PO, Zubiri L, Naranbhai V, Carrington M, Gusev A, Reynolds KL, LeBoeuf NR, Asgari MM, Kwatra SG, Semenov YR